Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality
- PMID: 33259917
- PMCID: PMC7698675
- DOI: 10.1016/j.ijantimicag.2020.106254
Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality
Conflict of interest statement
Declaration of Competing Interests None to declare
Comment in
-
Reply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'.Int J Antimicrob Agents. 2021 Feb;57(2):106261. doi: 10.1016/j.ijantimicag.2020.106261. Epub 2020 Dec 13. Int J Antimicrob Agents. 2021. PMID: 33321211 Free PMC article. No abstract available.
References
-
- Catteau L, Dauby N, Montourcy M. Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19 : a nationwide observational study of 8075 participants. Int J antimicrob agents. 2020;56(4) doi: 10.1016/j.ijantimicag.2020.106144. https://doi.org/ - DOI - PMC - PubMed
-
- Pan H, Peto R, Abdool Karim Q et al. WHO Solidarity trial consortium. Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1 - DOI - PMC - PubMed
-
- Clinicaltrials.gov. Registry of clinical trials. DISCOVERY trial. https://clinicaltrials.gov/ct2/show/NCT04315948
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
